Trial intelligence / Profile preview

Povidone-Iodine Oral Rinse Study

NCT05239598Phase 2Completed

Sponsor
University of Pennsylvania
Start
Feb 2022
Primary completion
Jul 2022
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of povidone-iodine in coronavirus disease 2019 (COVID-19), sponsored by University of Pennsylvania. Started Feb 2022; status: completed.

02

Drugs

povidone-iodine
03

Conditions

coronavirus disease 2019 (COVID-19)

Beyond the preview

Go deeper on NCT05239598.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05239598.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call